The Medicine Maker / Issues / 2017 / Articles / Mar / Flow Chemistry Focus
Manufacture Small Molecules Ingredients Technology and Equipment Formulation Facilities & Equipment Technology & Manufacturing

Flow Chemistry Focus

Professor Steven Ley runs a research group at the Whiffen and Innovative Technology Centre in the Department of Chemistry, University of Cambridge, UK – and a significant focus of the group’s work right now is on flow chemistry and organic synthesis. We catch up with Daniel Fitzpatrick, a PhD student with the group, to find out how the group is working to synthesize a range of APIs on a single reactor platform that uses flow chemistry and a clever cloud-based system.

03/27/2017 1 min read

Share

Recommended

Related Content

The Final Frontier?
Small Molecules
The Final Frontier?

December 1, 2014

0 min read

The Galactic Grant Competition encourages companies to use the International Space Station for pharmaceutical R&D

Calculate – Don’t Estimate – Drug Development Costs
Small Molecules
Calculate – Don’t Estimate – Drug Development Costs

December 1, 2014

0 min read

Researchers estimate the cost of drug development at over $1 billion, while others say it’s less than $100 million. Who’s right? And how can we accurately determine the true costs?

Electrifying R&D Acceleration
Small Molecules Analytical Science
Electrifying R&D Acceleration

December 2, 2014

0 min read

Electrochemical reaction cells are finding new applications in the pharma R&D lab that could offer big time and cost savings...

United Science Stands
Small Molecules Standards & Regulation
United Science Stands

December 2, 2014

0 min read

Sitting Down With… William Chin, Executive Vice President, Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA).